Deadline: 31-Jan-23
If you are a medical technology (MedTech) startup looking to enter the Asia Pacific market or region, MedTech Innovator is excited to announce that the applications for the premier annual accelerator Program for 2023 are now open.
Shortlisted startups will be invited to pitch across their various in-person and virtual pitch events, in front of their corporate and strategic partners, which are great for those who are looking for more exposure to notable players in the industry.
After which, they will be selecting 20 brilliant startups to join their Cohort for their annual MedTech Innovator Asia Pacific Accelerator Program which includes the opportunity to be matched with highly-qualified mentors in accordance to your startup’s needs as well as a chance to win the US $175,000 in non-dilutive cash Grand Prize.
Asia Pacific Program Benefits
- MedTech Innovator Pitch – The highest scoring companies from the online application review are invited to participate in regional pitch events, awarding the opportunity to present to a variety of industry-leading judges and key opinion leaders. In-person pitch event judges include members of the MedTech Innovator leadership team, investors, providers, and senior executives from world-class multinationals and medtech companies. Historically, participation has resulted in financial investment, recruitment of board advisors, and establishment of research partnerships for startups. All companies invited to pitch will be provided with review feedback summaries based on their online application and in-person pitch.
- MedTech Innovator Cohort – Shortlisted companies will be invited to participate in the MedTech Innovator Cohort. These companies will receive complimentary registration to APACMed’s Asia Pacific MedTech Forum in 2023. At this gathering of industry leaders from across the Asia Pacific, companies will participate in the MedTech Innovator Showcase, an on-stage interactive program. The showcase highlights the most innovative companies in sector-based sessions, moderated by leading corporate executives and investors. Opportunities will also include networking and pitching to investors, manufacturers, providers. All cohort companies will receive customized mentorship and the eligibility to compete for the Grand Prize.
Eligibility Criteria
- All early- to mid-stage medical device, diagnostic, or digital health companies are encouraged to apply.
- Companies that are accepted to the program must commit a co-founder or senior member of their leadership team to attend APACMed’s Asia Pacific MedTech Forum in 2023. All companies selected for the showcase will prepare a 1-minute pitch video to be played during their showcase session at the Asia Pacific MedTech Forum.
- MedTech Innovator is a nonprofit and does not require equity from participating companies.
For more information, visit MedTech.
